Related Experiment Video
Updated: Jan 25, 2026

Generation of Myospheres From hESCs by Epigenetic Reprogramming
Published on: June 21, 2014
Epigenetic reprogramming for ocular aging and disease: Mechanisms, biomarkers, and the road to the clinic
Junwon Lee1, Minseok Han2, Kaixiang Wang3
1Paul F. Glenn Center for Biology of Aging Research, Department of Genetics, Blavatnik Institute, Harvard Medical School (HMS), 77 Avenue Louis Pasteur, Boston, MA, 02115, USA; Department of Ophthalmology, Yonsei University College of Medicine, Institute of Vision Research, Gangnam Severance Hospital, 211, Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.
Abstract:
The eye's visual function relies on retinal neural cells that are long-lived, post-mitotic, and possess minimal regenerative capacity. These combined properties render them exceptionally vulnerable to the cumulative damage that drives age-related functional decline. Accumulating evidence now implicates epigenetic alterations, such as aberrant DNA methylation and histone modifications, not merely as correlates of aging but as fundamental drivers of aging and disease. These changes disrupt the stable gene expression programs required to maintain cellular identity and function, thereby contributing to the pathogenesis of irreversible blinding diseases like glaucoma and age-related macular degeneration (AMD). Unlike immutable genetic mutations, the reversible nature of these epigenetic marks offers a novel therapeutic paradigm. Epigenetic reprogramming, a strategy involving the transient expression of Yamanaka factors or chemical cocktails, provides a powerful means to reset this dysregulated epigenetic landscape and restore cells to a more youthful state. Compelling preclinical studies have validated this approach by demonstrating vision restoration in models of optic neuropathy through the rejuvenation of damaged and aged neurons. This review provides a comprehensive overview of ocular aging from an epigenetic perspective, examines the promise and potential concerns of epigenetic reprogramming, and discusses the future of rejuvenation therapies in ophthalmology.
Insights
Epigenetic alterations drive eye aging and vision loss. Epigenetic reprogramming offers a promising therapeutic strategy to restore youthful function and vision in age-related blinding diseases.
Area of Science:
- Ophthalmology
- Epigenetics
- Cellular Aging
Background:
- Retinal neural cells are vulnerable to age-related damage due to limited regeneration.
- Epigenetic alterations (DNA methylation, histone modifications) are key drivers of aging and diseases like glaucoma and age-related macular degeneration (AMD).
- These epigenetic changes disrupt cellular identity and function, leading to irreversible vision loss.
Purpose of the Study:
- To provide a comprehensive overview of ocular aging from an epigenetic perspective.
- To examine the therapeutic potential and concerns of epigenetic reprogramming for vision restoration.
- To discuss the future of rejuvenation therapies in ophthalmology.
Main Methods:
- Review of accumulating evidence on epigenetic alterations in ocular aging.
- Analysis of preclinical studies on epigenetic reprogramming for vision restoration.
- Discussion of Yamanaka factors and chemical cocktails for epigenetic resetting.
Main Results:
- Epigenetic reprogramming can reset dysregulated epigenetic landscapes, restoring cells to a more youthful state.
- Preclinical studies demonstrate vision restoration in models of optic neuropathy via neuronal rejuvenation.
- Epigenetic marks are reversible, offering a novel therapeutic avenue distinct from genetic mutations.
Conclusions:
- Epigenetic reprogramming presents a promising therapeutic paradigm for age-related blinding diseases.
- Rejuvenation therapies hold significant potential for restoring vision and improving ocular health.
- Further research is needed to address concerns and optimize epigenetic reprogramming strategies in ophthalmology.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Design Example: Alignment of a Road Line Using GIS
Chronic Kidney Disease II: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Coronary Artery Disease III: Clinical Manifestations

